UNSPSC 51273015: Cyclomethycaine hydrochloride

This classification denotes the hydrochloride form of an anesthetic agent with the molecular formula C22H33NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 15E9I74NZ8. European Medicines Agency schedules cyclomethycaine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06855MIG. The term CYCLOMETHYCAINE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 13, no. 12, 1959, list 3. ).

UNSPSC 51273015 Cyclomethycaine hydrochloride, a Commodity code, shows minimal recent state and local procurement activity aligned with its narrow pharmaceutical active-ingredient scope. The three most recent opportunities tagged to this code are actually procuring naloxone, direct-to-manufacturer prescription program management, and multi-source generic pharmaceuticals and OTC products—none of which are cyclomethycaine or local anesthetics. The code does not reflect what state and local governments are currently buying under this classification, and no recent solicitations target cyclomethycaine hydrochloride specifically.

The mismatch suggests either miscoding in the source data or that cyclomethycaine hydrochloride is not a procurement category in active use by state and local bodies. The recent opportunities instead represent broader pharmaceutical purchasing strategies: Seminole County, Florida is procuring naloxone and drug deactivation systems through an IFB (response due July 26, 2023); the Texas Health and Human Services Commission issued an RFI exploring direct-to-manufacturer prescription programs (April 2026); and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) released an RFP for generic multi-source pharmaceuticals and OTC products across participating state and local facilities (response due March 26, 2026). These solicitations reflect state and county procurement of public-health and workforce-pharmacy products, not specialized local anesthetics. Without substantive recent activity under the code as tagged, pursuit of opportunities labeled 51273015 warrants verification that the coding is accurate before investment in bid preparation.